CoChat

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Aims: Resting heart rate (RHR) has been shown to be associated with cardiovascular outcomes in various conditions. It is unknown whether different levels of RHR and different associations with cardiovascular outcomes occur in patients with or without diabetes, because the impact of autonomic neuropathy on vascular vulnerability might be stronger in diabetes. Methods and results: We examined 30 937 patients aged 55 years or older with a history of or at high risk for cardiovascular disease and after myocardial infarction, stroke, or with proven peripheral vascular disease from the ONTARGET and TRANSCEND trials investigating ramipril, telmisartan, and their combination followed for a median of 56 months. We analysed the association of mean achieved RHR on-treatment with the primary composite outcome of cardiovascular death, myocardial infarction, stroke, hospitalization for heart failure, the components of the composite primary outcome, and all-cause death as continuous and categorical variables. Data were analysed by Cox regression analysis, ANOVA, and χ2 test. These trials were registered with ClinicalTrials.gov.number NCT00153101. Patients were recruited from 733 centres in 40 countries between 1 December 2001 and 31 July 2008 (ONTARGET) and 1 November 2001 until 30 May 2004 (TRANSCEND). In total, 19 450 patients without diabetes and 11 487 patients with diabetes were stratified by mean RHR. Patients with diabetes compared to no diabetes had higher RHRs (71.8 ± 9.0 vs. 67.9 ± 8.8, P < 0.0001). In the categories of <60 bpm, 60 ≤ 65 bpm, 65 ≤ 70 bpm, 70 ≤ 75 bpm, 75 ≤ 80 bpm and ≥80 bpm, non-diabetic patients had an increased hazard of the primary outcome with mean RHR of 75 ≤ 80 bpm (adjusted hazard ratio [HR] 1.17 (1.01–1.36)) compared to RHR 60 ≤ 65 bpm. For patients with in-trial RHR ≥80 bpm the hazard ratios were highest (diabetes: 1.96 (1.64–2.34), no diabetes: 1.73 (1.49–2.00), For cardiovascular death hazards were also clearly increased at RHR ≥80 bpm (diabetes [1.99, (1.53–2.58)], no diabetes [1.73 (1.38–2.16)]. Similar results were obtained for hospitalization for heart failure and all-cause death while the effect of RHR on myocardial infarction and stroke was less pronounced. Results were robust after adjusting for various risk indicators including beta-blocker use and atrial fibrillation. No significant association to harm was observed at lower RHR. Conclusion: Mean RHR above 75–80 b.p.m. was associated with increased risk for cardiovascular outcomes except for stroke. Since in diabetes, high RHR is associated with higher absolute event numbers and patients have higher RHRs, this association might be of particular clinical importance in diabetes. These data suggest that RHR lowering in patients with RHRs above 75–80 b.p.m. needs to be studied in prospective trials to determine if it will reduce outcomes in diabetic and non-diabetic patients at high cardiovascular risk. Clinical Trial registration: http://clinicaltrials.gov.Unique identifier: NCT00153101.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehy808

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

See all 60

Metadata

Authors
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Ukena, C., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., Sliwa, K., Marx, N., Weber, M. A., Williams, B., & Yusuf, S.
Affiliations
  • Universitätsklinikum des Saarlandes (DE)
  • Statistical Consultant , 55218 Ingelheim, Germany
  • Population Health Research Institute (CA)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Milano-Bicocca (IT)
  • Hypertension Unit, Hospital CIínico Universitario, University of Valencia , Av. de Blasco Ibáñez, 13, 46010 València, Spain
  • University of Cape Town (ZA)
  • Universitätsklinikum Aachen (DE)
  • State University of New York (US)
  • National Institute for Health and Care Research (GB)
Corresponding author
Böhm, Michael
Venue
European Heart Journal
Published
2018-12-24
Volume
41
Issue
2
Pages
231-238
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2906096545
Cited by
55
References
41
Citations by year
2026: 6 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 8 · 2021: 9 · 2020: 6 · 2019: 1
FWCI
3.03
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Research Bank (Australian Catholic University) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
  • Steering Committees of ONTARGET and TRANSCEND
  • Deutsche Forschungsgemeinschaft (SFB TTR 219)
  • Astra Zeneca
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
resting heart rate, cardiovascular outcomes, diabetes mellitus, autonomic neuropathy, cardiovascular risk, ramipril, telmisartan, ONTARGET trial, TRANSCEND trial, cardiovascular mortality, myocardial infarction, stroke, heart failure hospitalization, all-cause mortality, ACE inhibitors, angiotensin receptor blockers, high cardiovascular risk patients, elderly patients
MeSH terms
Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Heart Rate, Humans, Male, Middle Aged, Prospective Studies, Rest, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. https://app.cochat.ai/papers/10.1093/eurheartj/ehy808
The paper
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Ukena, C., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., Sliwa, K., Marx, N., Weber, M. A., Williams, B., & Yusuf, S. (2020). Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. European Heart Journal. https://doi.org/10.1093/eurheartj/ehy808

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.